Testosterone and Cardiovascular Risk: TRAVERSE Trial and New FDA Label Change
Mohit Khera, MD, MBA, MPH, discusses testosterone therapy and cardiovascular risk, focusing on the TRAVERSE trial and FDA label changes.
Read More
Latest Videos
Transurethral Ultrasound Guided Prostate Ablation (TULSA): Clinical Trials and Real-world Results
Christian P. Pavlovich, MD, examines the use of TULSA in prostate cancer treatment, highlighting its technique, outcomes, and future potential.
Read More
Managing the Post Radiation Bladder Neck and Proximal Urethral Stricture Challenges
Jay Simhan, MD, FACS, explores the challenges of post-radiation bladder neck and proximal urethral strictures.
Read More
Should Screening be Altered Based on Germline and Family History?
Sigrid V. Carlsson, MD, PhD, MPH, explores the role of genetics in risk-stratified prostate cancer screening.
Read More
PCa Commentary | Volume 202 – June 2025
Edward Weber, MD, discusses the PSMAfore protocol, moving the option of using [177Lu]-PSMA-617 front-forward in early progressive metastatic castration-resistant prostate cancer (mCRPC).
Read More